Aptose Biosciences's total assets for Q3 2025 were $6.34M, an increase of 13.41% from the previous quarter. TSE:APS total liabilities were $25.79M for the fiscal quarter, a 29.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.